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ABSTRACT
Objectives: The hypothesis of the study was that if
the gut microbiota is involved in the development of
atherosclerotic cardiovascular and cerebrovascular
diseases (CVDs), total colectomy may reduce the long-
term risk of CVDs. The aim was therefore to investigate
the risk of CVD in patients after a total colectomy
compared with patients undergoing other types of
surgery, which are not expected to alter the gut
microbiota or the CVD risk.
Setting: The Danish National Patient Register
including all hospital discharges in Denmark from
1996 to 2014.
Participants: Patients (n=1530) aged 45 years and
above and surviving 1000 days after total colectomy
without CVDs were selected and matched with five
control patients who were also free of CVD 1000 days
after other types of surgery. The five control patients
were randomly selected from each of the three surgical
groups: orthopaedic surgery, surgery in the
gastrointestinal tract leaving it intact and other
surgeries not related to the gastrointestinal tract or
CVD (n=22 950).
Primary and secondary outcome measures: The
primary outcome was the first occurring CVD event in
any of the seven diagnostic domains (hypertensive
disorders, acute ischaemic heart diseases, chronic
ischaemic heart disease, cardiac arrhythmias, heart
failure, cerebrovascular diseases and other arterial
diseases) and the secondary outcomes were the first
occurring event within each of these domains.
Results: Estimated by Cox proportional hazard
models, the HRs of the composite CVD end point for
patients with colectomy compared with the control
patients were not significantly reduced (HR=0.94, 95%
confidence limits 0.85 to 1.04). Among the seven CVD
domains, only the risk of hypertensive disorders was
significantly reduced (HR=0.85, 0.73 to 0.98).
Conclusions: Colectomy did not reduce the general
risk of CVD, but reduced the risk of hypertensive
disorders, most likely due to salt and water depletion
induced by colectomy. These results encourage a
reappraisal of the associations between gut microbiota
and CVD.
INTRODUCTION
While the host-microbial symbiosis may
beneﬁt both the microbiota and the human
host,1–4 recent studies suggest that the gut
Strengths and limitations of this study
▪ The major strength of the study is based on the
availability of information in the entire Danish
Patient Register from 1996 to 2014, which
allows historical prospective assessment of the
risk of new occurrences of cardiovascular and
cerebrovascular diseases (CVDs) during long-
term, essentially complete follow-up in patients
after colectomy by comparison with matched
patients that had undergone other types of
surgery.
▪ The nature and size of the study population pro-
vides adequate statistical power to detect any
associations of CVD risk with colectomy of likely
clinical relevance with little risk of biases, includ-
ing confounding by indications for surgery.
▪ The key limitations of the study with regard to
appraisal of the causal role of the gut microbiota
in development of CVDs are the necessity of
using non-validated routine clinical diagnosis of
CVDs reported at discharge from the hospitals,
lack of information about risk factors for CVDs,
and lack of information about the composition of
the gut microbiota both before and after the
surgery.
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microbiota is involved in the development of atheroscler-
otic cardiovascular and cerebrovascular diseases
(CVDs).5–7 A harmful microbial composition, possibly
combined with a disrupted intestinal barrier, may
induce a state of intestinal dysbiosis leading to systemic
inﬂammation, or speciﬁc bacterial fermentation.2 8–10
Increased lipopolysaccharide diffusion to the circulation
through a disrupted intestinal barrier may lead to
metabolic endotoxaemia which may induce systemic
inﬂammation.1 11–13 A low-grade inﬂammatory origin
of CVD has been suggested by previously observed ele-
vated inﬂammatory markers among diseased in-
dividuals.1 11 14–17 Speciﬁc bacterial fermentation in
the gut may lead to higher levels of trimethylamine-N-
oxide, which has been suggested to promote atherogen-
esis.8–10 18 However, the direction of the causal relation-
ship between the gut microbiota and the elevated risk of
CVD is still unknown.8–10 12 19 As recently emphasised by
Hanage,20 it is important to request evidence for
changes in the risk of the presumed associated diseases
by interventions affecting the gut microbiota.
Since the greatest part by far of the gut microbiota is
carried in the colon, we suggest that patients who have
had a total colectomy and have been carrying the overall
harmful microbiota will beneﬁt from the removal of the
colon, whereas those carrying the beneﬁcial microbiota
will either not be affected by this procedure or be less
likely to suffer from an increased CVD risk. The high
frequency of CVD in the Western world may imply that a
harmful gut microbiota is prevailing in this population.
On this basis, we hypothesise that total colectomy in
patients from this part of the world may be expected to
reduce the CVD risk. To test this hypothesis, we com-
pared the long-term occurrence of a panel of different
CVD diagnoses in patients who have had a total colec-
tomy with patients undergoing several other types of
surgery not related to CVD and leaving the colon intact.
METHODS
Population
For this study, we used the nationwide Danish National
Patient Register covering all hospital contacts for
patients from 1996 to 2014, during which period the dis-
charge diagnoses were coded according to the
International Classiﬁcation of Diseases, 10th Edition
(ICD-10).21 There were a total of 88.8 million hospital
encounters for 6.6 million patients in the data set.
Within this data set, we identiﬁed those who have had
total colectomy, and three series of control patients
selected as described below. The outcome of interest was
the occurrence of CVD diagnoses during the years after
colectomy in patients who had not got a CVD diagnosis
until surgery, or during a period of stabilisation follow-
ing surgery. To optimise the comparability between the
colectomy group and the control groups, we restricted
the selection of control groups according to a set of
selection criteria of presumed inﬂuence on the
subsequently observed risk of CVD as explained in the
following section.
Exposure and control groups
The colectomy group was selected according to the
code JFH in the Scandinavian NOMESCO Classiﬁcation
of Surgical Procedures,22 which covers total removal of
the large intestine with or without ileostomy, hence
without or with an ileorectal pouch, respectively. The
control group was selected from the three groups of
patients who had undergone other types of surgery: any
orthopaedic surgery, any abdominal surgery leaving the
colon intact, and other major surgeries, unrelated to the
gastrointestinal tract or the cardiovascular and cerebro-
vascular system (see online supplementary table S1). To
avoid the possible inﬂuence of morbidity and mortality
related to the surgery as such, we deﬁned the colectomy
group and the control group as those who were alive
and free of previous CVD diagnoses at 1000 days after
colectomy and the corresponding time points in the
control group, that is, 1000 days after surgery. The
choice of 1000 days was based on the cumulative hazard
plots of all-cause mortality for the colectomy group and
the control group (see online supplementary ﬁgure S1);
approximately until that point in time, the colectomy
group had a much higher mortality, but thereafter the
slopes of the cumulative hazards were stable in both
groups, although still steadily higher in the colectomy
group. During the available follow-up period, the
younger patients are expected to have a rather low
cumulative risk of CVD, and we therefore restricted the
analyses to patients who had colectomy at the age of
45 years and above. For each of these patients with colec-
tomy, ﬁve patients within each of the three surgical
groups were matched by gender, date of birth (±12
months), date of surgery (±12 months) and otherwise
randomly drawn from the patients fulﬁlling the selection
criteria in the entire register population.
Colectomy subgroups
The underlying diseases for which colectomy was per-
formed may inﬂuence the subsequent risk of CVD.
Therefore, the analyses were repeated after dividing the
patient group with colectomy and the matched control
groups accordingly. One group included patients with
colectomy with co-occurrence of inﬂammatory bowel dis-
eases (IBD) at the time of surgery (n=791): Crohn’s
disease (K50), ulcerative colitis (K51), and other non-
infective gastroenteritis and colitis (K52). The other
group included patients with colectomy with a cancer
diagnosis: any C-diagnoses in ICD-10 (n=531). Patients
with cancer and IBD were present in both groups
(n=41).
Primary and secondary CVD outcomes
Seven CVD domains, covering 32 different CVD diagno-
ses, were selected from the ICD-10 classiﬁcation (see
online supplementary table S2). They cover hypertensive
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diseases (ICD-10 codes I10 to I13), acute ischaemic
heart diseases (I20, I21, I24, I46), chronic ischaemic
heart disease (I23, I25, I51), cardiac arrhythmias (I44–
I49), heart failure (I50), cerebrovascular diseases (I61 to
I69) and other arterial diseases (I35, I70–I74). These
diagnoses were included in a composite measure of the
ﬁrst occurring CVD diagnosis, which is considered as
the primary end point. In supplementary analyses, the
ﬁrst occurring diagnosis within the seven CVD domains
was investigated as well.
Statistical analyses
Cox proportional hazard models were used to assess the
risk of CVD in the patients with colectomy compared
with the risk of CVD in the control group from the
1000 days after the colectomy date and 1000 days after
the date of surgery in the control group. Gender and
age were included as covariates in the model. HRs with
95% conﬁdence limits were estimated. Assessment of the
assumption of proportional hazards in the Cox regres-
sion models with regard to estimates of the HR of CVDs
for the colectomy group versus the control group
showed no signiﬁcant deviations.
The primary analysis was an estimation of the HR for
CVD as a composite end point in the colectomy group
compared to the control group. In additional analyses,
the HRs of CVD within each of the seven CVD domains
were evaluated, as were the HRs of CVD in stratiﬁed
groups with co-occurring IBD and cancer. Patients were
censored from the analyses either at the time of death
or end of follow-up, but not at the occurrence of diagno-
ses from the other CVD groups when analysing the
seven CVD domains.
Ethical considerations
This study is purely based on register-based data from
the National Patient Register. Use of data has been
approved by the Danish Data Protection
Agency, Copenhagen (ref: 2010-54-1059) and the
National Board of Health, Copenhagen (ref:
7-505-29-1624/1).
RESULTS
Among the 5429 patients with colectomy aged 45 and
above in the register, 2179 died before the 1000 days
after surgery, and 659 had less than 1000 days of
follow-up. Among the 2591 known to be alive 1000 days
after surgery, CVD diagnoses were already made before
the time of colectomy surgery among 690 patients, and
CVD is present in 371 at the start of follow-up. Thus, the
colectomy group at risk of ﬁrst occurrence of CVD from
1000 days after surgery and onwards included 1530
patients. The control group matched to this colectomy
group included 7650 patients from each of the three sur-
gical subgroups, with 22 950 unique control patients
included in the total. The average age of the included
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colectomy group at the date of surgery was 60.5 years,
and 49% of them were men (table 1).
Patients were followed for a total of 231 452 years with
a mean follow-up time from the 1000 days and onwards
of 9.0 and 9.5 years, respectively, for patients with colec-
tomy and control patients. During follow-up, 25.8% of
the patients with colectomy (n=394) had a CVD diagno-
sis, compared to 28.6% of control patients (n=6564).
Table 1 shows the distribution of CVD diagnoses in the
seven domains and across the colectomy group and the
control group.
The time-corresponding cumulative hazards of the
ﬁrst occurring composite CVD end point, shown in
ﬁgure 1, suggest that the risk of CVD was lower in the
colectomy group than in the combined control group.
However, the reduction in risk was insigniﬁcant, with an
HR of 0.94 with 95% conﬁdence limits of 0.85 to 1.04
(p=0.22) (table 2). The HR of obtaining a CVD diagno-
sis in the subgroups of patients with colectomy with IBD
and cancer showed virtually the same results (table 3).
The results pertaining to each of the seven CVD
domains revealed that colectomy was associated with ten-
dencies of reduced HRs in most domains and with a stat-
istically signiﬁcant reduction for hypertensive disorders
(table 4).
DISCUSSION
This study investigated the long-term risk of CVD follow-
ing total colectomy across a panel of diagnoses, which
are presumed to be based mainly on atherosclerotic dis-
eases. The postsurgical mortality rate after colectomy
was high. By limiting the risk period to 1000 days follow-
ing surgery and onwards, the all-cause mortality was
stable in the colectomy and the control groups, although
still with a steadily higher mortality in the colectomy
group. Compared with the control group, the patients
with colectomy surviving and remaining free of CVDs
through 1000 days following surgery had a slightly and
insigniﬁcantly reduced risk of CVD when analysed as a
composite end point, irrespective of co-occurring IBD
or cancer and which of the three surgical control groups
were used. The same pattern was seen across the CVD
domains except for the hypertensive disorders, of which
the risk was signiﬁcantly reduced.
Given the results reported from previous studies of the
possible involvement of the intestinal microbiota in ath-
erosclerosis,6 8–10 18 we expected a considerably reduced
risk of CVD in patients who had their presumed overall
harmful intestinal microbiota reduced by colectomy.
However, as discussed in the following paragraphs,
various limitations of the study may have masked such
effects.
One possibility is an inaccurate classiﬁcation of CVDs.
However, since the composite CVD end point includes
most CVD domains, misclassiﬁcation is not suspected to
be a problem in estimating the risk of any CVD, whereas
a comparison of risks across a speciﬁc CVD diagnosis
may be more problematic. It was reassuring that the
same results were obtained in the more distinct groups
with acute CVDs. Thus, we do not suspect that systematic
or random misclassiﬁcation has inﬂuenced the results.
On the other hand, depending on the severity of the
underlying disease, there may be differences in the
Figure 1 Cumulative hazards of
the first occurring cardiovascular
and cerebrovascular diagnosis
(CVD) in patients with colectomy
(n=1530) and control patients
(n=22 950). The HR was 0.94,
95% confidence limits 0.85 to
1.04, of CVD in patients with
colectomy compared with the
matched control patients.
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number of hospital contacts and thus in the possibility
of obtaining a diagnosis of chronic CVD. To take care of
such possible bias, different types of surgery were used
to form the control groups in which similar opportun-
ities for diagnosis of chronic CVD may exist.
In addition, bias through confounding by
indication—meaning that having surgery performed
depends on disease severity and presence of comorbid-
ities before surgery—should also have been minimised
through the selection of control patients undergoing dif-
ferent surgical procedures. In theory, it would be ideal
to compare the patients with colectomy with a group of
patients with the same underlying diseases and with the
same a priori risk of CVD, but not undergoing colec-
tomy. However, identifying such a control group in the
register is not feasible; colectomy is performed on indi-
cations based on the type and severity of the underlying
diseases, and comparable patients who have not had col-
ectomy, but who have the same type and severity of dis-
eases combined with the same a priori CVD risk, are
unlikely to exist in this population.
Patients with colectomy and control patients with a
known history of any CVD were censored from the ana-
lyses to reduce the possibly differently increased risk of
recurrent CVDs. Although of interest, the study popula-
tion was not suitable for assessment of the effect of col-
ectomy on risk of recurrence of CVDs. A bias may arise
due to the lack of data on prior CVDs for patients who
had their surgery in the beginning of the study period,
but it is assumed that this problem inﬂuences the colec-
tomy and the control groups similarly.
By restricting our study group to patients who had col-
ectomy at the age of 45 years and above, we have
excluded a younger group of patients who were unlikely
to experience a CVD event in the available observation
time unless they were particularly predisposed.
Following the same entry and follow-up criteria, there
were 978 patients in the age range 30–44 years who had
colectomy. However, only 84 (8.5%) of them and 1424
(9.7%) of the 14 670 matched control patients experi-
enced a CVD event. With these numbers and distribu-
tion of events, we ﬁnd it unlikely that they can change
the conclusion, and, moreover, the numbers do not
allow the corroborating stratiﬁed analyses. It would be
interesting to continue a follow-up of this group through
the years where the CVD risk increased to the level of
the current group.
The patients undergoing total colectomy usually suffer
from severe gastrointestinal diseases, the majority from
IBD and cancer. IBD has been associated with elevated
risk of CVD, but primarily when the disease ﬂares
arise.17 23–27 Lifestyle differences before and after
surgery, such as smoking, may also inﬂuence the CVD
risk. Since smoking may relieve the symptoms in patients
Table 2 HRs with 95% CIs of any first occurring CVD diagnosis in colectomy and surgical control patients as well as for
surgical subgroups
Number with
diagnosis/total HR (95% CI) p Value
Patients with colectomy 394/1530
Control patients* 6564/22 950 0.94 (0.85 to 1.04) 0.22
Surgical subgroups
Orthopaedic surgery 2148/7650 0.97 (0.87 to 1.07) 0.51
Surgery in the GI tract leaving it intact 2223/7650 0.92 (0.82 to 1.02) 0.11
Other major surgery not in the GI tract 2193/7650 0.93 (0.84 to 1.04) 0.20
*Age and sex matched, but otherwise randomly selected control patients; five for each surgical comparison group of orthopaedic surgery,
surgery in the GI tract, and other major surgery not in the GI tract.
Results are adjusted for age and sex.
CVD, cardiovascular and cerebrovascular; GI, gastrointestinal.
Table 3 HRs, with 95% CIs of a CVD diagnosis by groups of patients with colectomy with either co-occurring IBD or cancer
compared with the control patients
Number with diagnosis/total HR (95% CI) p Value
Co-occurrence of IBD
Patients with colectomy 191/791
Control patients* 3198/11 865 0.88 (0.76 to 1.02) 0.08
Co-occurrence of cancer
Patients with colectomy 133/531
Control patients 2385/7965 0.93 (0.78 to 1.11) 0.41
*Age and sex matched, but otherwise randomly selected control patients; five for each surgical comparison group of orthopaedic surgery,
surgery in the GI tract, and other major surgery not in the GI tract.
Results are adjusted for age and sex.
CVD, cardiovascular and cerebrovascular; GI, gastrointestinal; IBD, inflammatory bowel disease.
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with IBD, those who have had colectomy may have been
smoking and hence have a greater CVD risk than other
patients.28 Moreover, the ﬁnding of a continuously
increased total mortality in the colectomy group com-
pared to the control group may indicate that they are at
increased risk of health problems that could have masked
the diagnosis of CVDs. These biases may hide a reduction
in CVD risk after colectomy from a level higher than in
the control group. On the other hand, the ﬁnding of vir-
tually similar effects of colectomy for IBD and for cancer
suggests that these biases are limited.
In this regard, patients who had colectomy because of
familial adenomatous polyposis would be of particular
interest to investigate because of the likely absence of a
condition inﬂuencing the CVD risk. However, the
national register includes far too few of such patients for
reliable analyses (10 of the colectomy patients included
in the analyses and 21 of the 30–44-year-old patients
with colectomy).
The effect of colectomy on CVD risk may have been
minimised for various other reasons. Thus, the patient
groups may be a mixture of patients with intestinal micro-
biota that are either increasing or decreasing the CVD risk
in such a way that the effect of colectomy in the entire
group becomes a net result of interference with oppositely
acting microbiota. The risk may also be modiﬁed by the
microbiota associated with the diseases leading to
colectomy and by the alterations in the microbiota in the
remaining intestine following colectomy. Furthermore, the
study groups may encompass individuals at low risk of CVD
that is difﬁcult to reduce further, possibly due to dietary
modiﬁcations before and after surgery.29–31 Effects of colec-
tomy may also depend on various characteristics of the
individuals, such as gender, age, the time frame beyond the
present observation period, comorbidities such as diabetes
and the CVD history. These aspects may be addressed in
future studies, which, however, will require additional infor-
mation and an even greater study population.
The signiﬁcantly reduced HR of hypertensive disor-
ders in the patients with colectomy compared to the
other surgical groups may be explained by the salt and
water depletion, which is a well-known consequence for
patients who do not have the colon available for
reabsorption of salt and water.32 Since hypertension is a
well-established risk factor for most of the other CVDs, it
is plausible that the overall, though insigniﬁcant, ten-
dency to a lower CVD risk after colectomy may be due
to an effect on blood pressure.
CONCLUSION
While keeping the reservations in mind, we conclude
that removal of the major reservoir of the gut microbiota
by colectomy did not reduce the risk of CVDs in this
Table 4 HRs with 95% CIs of a CVD across the seven CVD domains in patients with colectomy compared with control
patients
CVD-ICD-10 subdomains
Number with
diagnosis/total HR (95% CI) p Value*
Hypertensive disorders (I10–I13)
Patients with colectomy 187/1530
Control patients† 3474/22 950 0.85 (0.73 to 0.98) 0.03
Acute ischaemic heart diseases (I20, I21, I24, I46)
Patients with colectomy 100/1530
Control patients 1751/22 950 0.91 (0.75 to 1.12) 0.38
Chronic ischaemic heart disease (I23, I25, I51)
Patients with colectomy 63/1530
Control patients 1224/22 950 0.83 (0.64 to 1.07) 0.15
Cardiac arrhythmias (I44–I49)
Patients with colectomy 105/1530
Control patients 1854/22 950 0.92 (0.75 to 1.11) 0.38
Heart failure (I50)
Patients with colectomy 57/1530
Control patients 841/22 950 1.10 (0.84 to 1.44) 0.48
Cerebrovascular diseases (I61–I69)
Patients with colectomy 85/1530
Control patients 1422/22 950 0.96 (0.77 to 1.20) 0.72
Other arterial diseases (I35, I70–I74)
Patients with colectomy 65/1530
Control patients 1227/22 950 0.85 (0.67 to 1.10) 0.21
*Tests for whether the HRs are different from 1.00.
†The matched control patient group includes orthopaedic surgery, surgery in the gastrointestinal (GI) tract, and other major surgery not in the
GI tract (see web extra material for NOMESCO diagnoses included).
Results are adjusted for age and sex.
CVD, cardiovascular and cerebrovascular; GI, gastrointestinal; IBD, inflammatory bowel disease; ICD-10, International Classification of
Diseases, 10th Edition.
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population, except for the reduced risk of hypertensive
disorders. Whether other ways of modifying the gut
microbiota may have a beneﬁcial inﬂuence on CVD
remain to be investigated.
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